RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Ethics Channel

subscribe to Ethics newsletter
Special Topics : Ethics

   EMAIL   |   PRINT
Regulating stem cell research

May 11, 2007 - 12:03:55 PM , Reviewed by: Dr. Sanjukta Acharya
"Because human embryonic stem cell research is controversial," they say, "prospective donors need complete information about possible research uses of embryos, gametes, and tissue that they might donate. If donors have stated restrictions on the future uses of donated materials, CIRM-funded researchers must respect these."

 
[RxPG] Regulations governing human stem cell research must strive to assure strict oversight while simultaneously fostering scientific innovation through collaboration, says a group of scientists from the California Institute for Regenerative Medicine (CIRM), one of the world's largest supporters of such research.

In November 2004, California voters approved $3 billion over 10 years for public funding of stem cell research through the CIRM. In their policy paper in PLoS Medicine, Geoffrey Lomax, Zach Hall, and Bernard Lo discuss how CIRM came to adopt its legally binding regulations for the stem cell research it funds.

In addition to the goal of "setting high ethical standards," say the authors, there were five other crucial objectives that guided the regulations:

▪ Encourage research institutions and researchers to develop best practices for ethical conduct of human stem cell research
▪ Avoid unnecessary regulatory burdens
▪ Involve the public in developing regulations
▪ Be consistent with existing laws, regulations, and ethical guidelines
▪ Facilitate collaboration to accelerate scientific progress.

Dr Lomax and colleagues describe two innovative features of the regulations: the informed consent process and the protection of egg (oocyte) donors.

"Because human embryonic stem cell research is controversial," they say, "prospective donors need complete information about possible research uses of embryos, gametes, and tissue that they might donate. If donors have stated restrictions on the future uses of donated materials, CIRM-funded researchers must respect these."

And for oocyte donors, in addition to obtaining consent, researchers must ascertain that such donors fully comprehend eight essential features of the research. "In other research settings," say Dr Lomax and colleagues, "research participants often fail to understand the information in detailed consent forms." The CIRM regulations require that CIRM researchers evaluate whether women have fully understood the benefits and risks of oocyte donation.

The regulations, they say, were developed with extensive public input and are a "critical first step in increasing public trust and support for human stem cell research."



Advertise in this space for $10 per month. Contact us today.


Related Ethics News
Regulating stem cell research
Overcoming Ethical Constraints
Drug tests on animals may be unreliable: study
Waiting For Trial Results Sometimes Unethical
NHGRI Funds Assessment of Public Attitudes About Population-Based Studies on Genes and Environment
Physicians More Likely To Disclose Medical Errors That Would Be Apparent To The Patient
Doctors inadvertently help terminally ill patients to die sooner
Intellectual property law and the protection of traditional knowledge
Conscientious objection in medicine should not be tolerated
Yale guidelines for physician interactions with pharmaceutical industry

Subscribe to Ethics Newsletter

Enter your email address:


 About Dr. Sanjukta Acharya
This news story has been reviewed by Dr. Sanjukta Acharya before its publication on RxPG News website. Dr. Sanjukta Acharya, MBBS is the chief editor for RxPG News website. She oversees all the medical news submissions and manages the medicine section of the website. She has a special interest in diabetes and endocrinology.
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)